Cell cycle-dependent and ATM-independent expression of human Chk1 kinase
Yokos Kaneko(National Center for Geriatrics and Gerontology), Makoto Nakanishi(The Cancer Institute Hospital), Atsushi Fujimoto(Allen Institute for Brain Science), Hidetoshi Akita(National Center for Geriatrics and Gerontology), Kyoji Ikeda(National Center for Geriatrics and Gerontology), Motomu Terasawa(Nagoya University), Nobumoto Watanabe(RIKEN Center for Sustainable Resource Science), Kaoru Tominaga(Jichi Medical University), Akira Tachibana(Kagawa Prefectural Central Hospital), Hirobumi Morisaki(National Center for Geriatrics and Gerontology)
Cited by 151
Related Papers
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice
|Genes & Development|2000|469
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
|The EMBO Journal|2002|436